2019-13891. Medicare and Medicaid Programs; Risk Adjustment Data Validation  

  • Start Preamble Start Printed Page 30983

    AGENCY:

    Centers for Medicare & Medicaid Services (CMS), HHS.

    ACTION:

    Proposed rule; request for additional comment; announcement of the release of additional data.

    SUMMARY:

    This document summarizes actions taken to date, requests public comment on additional subjects, and announces that CMS is releasing additional material, including study data, related to the Risk Adjustment Data Validation (RADV) provisions of the proposed rule titled “Medicare and Medicaid Programs; Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Program of All-inclusive Care for the Elderly (PACE), Medicaid Fee-For-Service, and Medicaid Managed Care Programs for Years 2020 and 2021” that was published in the November 1, 2018 Federal Register, 83 FR 55037. The comment period for the RADV provisions of this proposed rule ends on August 28, 2019.

    DATES:

    The comment period for CMS RADV provisions (that is, section II.C.2. of the November 1, 2018 proposed rule and proposed §§ 422.300, 422.310(e) and 422.311(a) of the regulation text) closes at 5 p.m. on August 28, 2019.

    ADDRESSES:

    In commenting, please refer to file code CMS-4185-P. Because of staff and resource limitations, we cannot accept comments by facsimile (FAX) transmission.

    Comments, including mass comment submissions, must be submitted in one of the following three ways (please choose only one of the ways listed):

    1. Electronically. You may submit electronic comments on this regulation to http://www.regulations.gov. Follow the “Submit a comment” instructions.

    2. By regular mail. You may mail written comments to the following address ONLY: Centers for Medicare & Medicaid Services, Department of Health and Human Services, Attention: CMS-4185-P, P.O. Box 8013, Baltimore, MD 21244-8013.

    Please allow sufficient time for mailed comments to be received before the close of the comment period.

    3. By express or overnight mail. You may send written comments to the following address ONLY: Centers for Medicare & Medicaid Services, Department of Health and Human Services, Attention: CMS-4185-P, Mail Stop C4-26-05, 7500 Security Boulevard, Baltimore, MD 21244-1850.

    For information on viewing public comments, see the beginning of the SUPPLEMENTARY INFORMATION section.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Jonathan Smith (410) 786-4671 or Joanne Davis (410) 786-5127.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    Inspection of Public Comments: All comments received before the close of the comment period are available for viewing by the public, including any personally identifiable or confidential business information that is included in a comment. We post all comments received before the close of the comment period on the following website as soon as possible after they have been received: http://www.regulations.gov. Follow the search instructions on that website to view public comments.

    I. Request for Public Comment

    On November 1, 2018, we published a proposed rule containing provisions related to the Risk Adjustment Data Validation (RADV) audit program, 83 FR 55037 through 55041 and 55077, including the proposal not to apply a Fee-for-Service Adjuster (FFS Adjuster) in any RADV extrapolated audit methodology. That proposal rested on two grounds. First, we conducted a study which indicated that diagnosis error in FFS claims data does not lead to systematic payment error in the Medicare Advantage (MA) program. Second, we suggested that it would be inequitable to correct any systematic errors made in the payments to audited plans only. We continue to welcome public comment on this proposal. We are also seeking comment on whether 42 U.S.C. 1395w-23—and in particular clause (a)(1)(C), which requires risk adjustment in subclause (a)(1)(C)(i), mandates a downward adjustment of risk scores in subclause (a)(1)(C)(ii), and includes provisions about risk adjustment for special needs individuals with chronic health conditions in subclause (a)(1)(C) (iii)—mandates an FFS Adjuster, prohibits an FFS Adjuster, or should otherwise be read to inform our proposal not to apply an FFS Adjuster in any RADV extrapolated audit methodology.

    II. Summary of Prior Notices

    Since we published the FFS Adjuster Study on October 26, 2018,[1] we have published several related notices.

    On December 27, 2018 (83 FR 66661), we announced an extension of the comment period for the RADV provisions until April 30, 2019 and a plan to release data underlying the October 26, 2018 FFS Adjuster Study.

    On March 6, 2019 (84 FR 8069), we announced the release of data underlying the FFS Adjuster Study, both through the Office of Enterprise Data Analytics (OEDA) and on the Private Plans Team website. Data made available to the public through a data use agreement included all of the following:

    • An input file originating from a dataset that Research Triangle Institute (RTI) supplied. It represents the calibration data that RTI used for the Centers for Medicare and Medicaid Services Hierarchical Condition Category (CMS-HCC) model version that CMS used to calculate 2009 MA payments.
    • An input file containing medical record review findings from a RADV-like review that CMS undertook on a sample of calendar year 2008 medical records.
    • FFS data containing 10 datasets that represent the entire 5 percent sample of all final 2004 and 2005 diagnosis codes used for MA model calibrations through 2011.
    • An HCC file containing the mapping from International Classification of Disease, 9th Revision diagnosis code to Version 12 of the CMS-HCC model. Diagnosis codes have been modified to remove decimals.
    • A file consolidating MA data for beneficiaries who meet eligibility criteria for Contract-Level Risk RADV audits from three sources: The adjusted Monthly Membership Report (MMR), the Model Output File (MOF), and the CMS Enrollment Database (EDB).
    • A file consolidating MA data for beneficiaries who did not meet all eligibility criteria for the Contract-Level RADV audits from three sources—adjusted MMR, MOF, and CMS EDB.
    • Additional documentation and data related to the RADV FFS Adjuster Study was posted on the Private Plans Team website at https://www.cms.gov/​Research-Statistics-Data-and-Systems/​Monitoring-Programs/​Medicare-Risk-Start Printed Page 30984Adjustment-Data-Validation-Program/​Resources.html. This data included a RADV Data Dictionary and Provisional Coefficients workbook.

    On April 30, 2019 (84 FR 18215), we announced an additional extension of the comment period for the RADV provision until August 28, 2019. We also announced that we would be releasing additional data underlying the FFS Adjuster Study, including additional data containing Protected Health Information, to all parties who entered an applicable data use agreement and paid the required fee. This data has been available since June 14, 2019. The forms and instructions to request this data and previously released data remain available via the CMS website at https://www.cms.gov/​research-statistics-data-and-systems/​files-for-order/​limiteddatasets/​. Updates to existing documentation related to the study data, as well as additional data without Protected Health Information, were posted on the CPI Private Plans Team website on April 25, 2019.

    III. Release of Additional Study Material and Further Request for Public Comment

    We have now replicated the FFS Adjuster Study and published a summary of that replication as an addendum to the study at: https://www.cms.gov/​Research-Statistics-Data-and-Systems/​Monitoring-Programs/​Medicare-Risk-Adjustment-Data-Validation-Program/​Resources.html. The results of the replication are broadly consistent with the initial implementation of the study. The purpose of this replication was to allow us to both test our initial results and release a more complete set of underlying data. Certain intermediate data elements not saved as part of the implementation of the initial study have been preserved and published in the addendum or at https://www.cms.gov/​Research-Statistics-Data-and-Systems/​Monitoring-Programs/​Medicare-Risk-Adjustment-Data-Validation-Program/​Resources.htm. In addition, the addendum contains further discussion of the study's assumptions and methodology. We are also releasing the programming language used to implement the replication of the study, available at https://www.cms.gov/​Research-Statistics-Data-and-Systems/​Monitoring-Programs/​Medicare-Risk-Adjustment-Data-Validation-Program/​Resources.html,, along with a description of the technical requirements for use of that programming language. It is our intention that the release of this programming language, together with the earlier release of the data used as inputs, will allow for robust public comment on the FFS Adjuster Study.

    We welcome public comment on that subject, and all subjects raised in this notice and the notices discussed previously, until 5 p.m. on August 28, 2019.

    Start Signature

    Dated: June 21, 2019.

    Seema Verma,

    Administrator, Centers for Medicare & Medicaid Services.

    End Signature End Supplemental Information

    Footnotes

    [FR Doc. 2019-13891 Filed 6-27-19; 8:45 am]

    BILLING CODE 4120-01-P

Document Information

Effective Date:
11/1/2018
Published:
06/28/2019
Department:
Centers for Medicare & Medicaid Services
Entry Type:
Proposed Rule
Action:
Proposed rule; request for additional comment; announcement of the release of additional data.
Document Number:
2019-13891
Dates:
The comment period for CMS RADV provisions (that is, section II.C.2. of the November 1, 2018 proposed rule and proposed Sec. Sec. 422.300, 422.310(e) and 422.311(a) of the regulation text) closes at 5 p.m. on August 28, 2019.
Pages:
30983-30984 (2 pages)
Docket Numbers:
CMS-4185-N4
RINs:
0938-AT59: Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs for Contract Year 2020; Risk Adjustment Data Validation (CMS-4185)
RIN Links:
https://www.federalregister.gov/regulations/0938-AT59/policy-and-technical-changes-to-the-medicare-advantage-and-the-medicare-prescription-drug-benefit-pr
PDF File:
2019-13891.Pdf
Supporting Documents:
» Medicare and Medicaid Programs: Policy and Technical Changes to the Medicare Advantage Program, etc.
» Medicare and Medicaid Programs: Risk Adjustment Data Validation
» Medicare and Medicaid Programs: Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Programs of All-Inclusive Care for the Elderly, Medicaid Fee-For-Service, and Medicaid Managed Care Programs for Years 2020 and 2021; CorrectionCMS-4185-NC
» Medicare and Medicaid Programs: Risk Adjustment Data Validation
» Medicare and Medicaid Programs: Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, etc.
» Medicare Program: Release of Data Underlying Risk Adjustment Data Validation Provisions CMS-4185-N2
» Medicare and Medicaid Programs: Risk Adjustment Data Validation
» Medicare and Medicaid Programs: Medicare Advantage, Medicare Prescription Drug Benefit, Program of All-inclusive Care for the Elderly, Medicaid Fee-For-Service, and Medicaid Managed Care Programs for Years 2020 and 2021; Policy and Technical Changes CMS-4185-P
CFR: (1)
42 CFR 422